 Chair of the Board of Directors, Sean P. Nolan, appointed Chief Executive Officer Board Director, Sukumar Nagendran, M.D., appointed President and Head of RD DALLAS, Dec. 16, 2022 GLOBE NEWSWIRE Taysha Gene Therapies, Inc. Nasdaq: TSHA, a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of ... The post Taysha Gene Therapies Announces Executive Leadership Changes appeared first on ForexTV... 